Target intelligence / Profile preview

Schlafen family member 12-like (SLFN12L)

Target
SLFN12L
Molecular classification
Other (Schlafen family protein; specifically, Group II intermediate Schlafen family protein, not a classical receptor, enzyme, transporter, or transcription factor)
01

Overview

Schlafen family member 12-like (SLFN12L) is an intermediate member of the human Schlafen family of proteins, predicted to be membrane-associated and structurally related to the murine Slfn4 protein[1][3]. The Schlafen family is characterized by shared N-, M-, and C-terminal domains and functions in immunity, cell differentiation, and potentially cancer biology[3]. SLFN12L has been associated with the regulation of immune homeostasis, specifically influencing lymphocyte subsets such as natural killer cells[1]. During chronic Helicobacter pylori infection, SLFN12L marks a population of myeloid-derived suppressor cells migrating to the gastric mucosa and is linked to preneoplastic transformation, suggesting a role in cancer development[1][3]. Although related proteins in the Schlafen family (notably SLFN12) have recognized roles in tumor differentiation, drug resistance, and immune regulation, SLFN12L itself has not been conclusively linked to any currently targeted therapeutic pathway nor to approved or investigational drugs[3]. The specific molecular mechanisms and clinical significance of SLFN12L are not well established and remain an active area of research[1][3]. Important clarification: - "SLFN5" is not an alias for SLFN12L; it is a separate long Schlafen family member[3], and any sources treating these as identical should be disregarded as incorrect. - Humans express both intermediate (SLFN12, SLFN12L) and long (e.g., SLFN5) Schlafen proteins, but SLFN12L is always distinct from SLFN5[2][3].

Other names
Schlafen family member 12-likeSLFN12L
02

Biological functions

Immune response modulation (regulates lymphocyte subset frequencies, especially natural killer (NK) cells)Myeloid-derived suppressor cell marker (marks GLI1-dependent myeloid-derived suppressor cells in Helicobacter infection)Potential role in epithelial cell differentiation (suggested by analogy to SLFN12)
03

Disease associations

Immune-related conditions (modulation of immune cell dynamics may contribute to immune-related diseases)Cancer (implicated in the transition of preneoplastic to gastric cancer cells in context of Helicobacter infection)Other (possible roles in infection and metaplasia)

Beyond the preview

Go deeper on Schlafen family member 12-like (SLFN12L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schlafen family member 12-like (SLFN12L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call